Structural insights into G protein-coupled receptor kinase function

Current Opinion in Cell Biology

Volumn 27, Issue 1, 2014, Pages 25-31

  Homan, Kristoff T ^a   Tesmer, John JG ^a  

^a UNIVERSITY OF MICHIGAN   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BALANOL; G PROTEIN COUPLED RECEPTOR KINASE; PAROXETINE; RHODOPSIN; TUBULIN; G PROTEIN COUPLED RECEPTOR; PHOSPHOLIPID;

AMINO TERMINAL SEQUENCE; BINDING SITE; HEART FAILURE; HEART VENTRICLE HYPERTROPHY; HUMORAL IMMUNITY; MOLECULAR BIOLOGY; MOLECULAR DOCKING; POLYMERIZATION; PRIORITY JOURNAL; PROTEIN CONFORMATION; PROTEIN FUNCTION; PROTEIN PHOSPHORYLATION; PROTEIN STRUCTURE; REVIEW; ANIMAL; ANTAGONISTS AND INHIBITORS; CHEMICAL STRUCTURE; CHEMISTRY; ENZYME ACTIVATION; HUMAN; METABOLISM; SIGNAL TRANSDUCTION;

ANIMALS; BINDING SITES; ENZYME ACTIVATION; G-PROTEIN-COUPLED RECEPTOR KINASES; HUMANS; MODELS, MOLECULAR; PHOSPHOLIPIDS; PROTEIN CONFORMATION; RECEPTORS, G-PROTEIN-COUPLED; SIGNAL TRANSDUCTION;

EID: 84888336227     PISSN: 09550674     EISSN: 18790410     Source Type: Journal    
DOI: 10.1016/j.ceb.2013.10.009     Document Type: Review

References (39)

1. Gurevich E.V., Tesmer J.J., Mushegian A., Gurevich V.V. G protein-coupled receptor kinases: more than just kinases and not only for GPCRs. Pharmacol Ther 2012, 133:40-69.
2. Mushegian A., Gurevich V.V., Gurevich E.V. The origin and evolution of G protein-coupled receptor kinases. PLoS One 2012, 7:e33806.
3. Singh P., Wang B., Maeda T., Palczewski K., Tesmer J.J. Structures of rhodopsin kinase in different ligand states reveal key elements involved in G protein-coupled receptor kinase activation. J Biol Chem 2008, 283:14053-14062.
4. Lodowski D.T., Pitcher J.A., Capel W.D., Lefkowitz R.J., Tesmer J.J. Keeping G proteins at bay: a complex between G protein-coupled receptor kinase 2 and Gβγ. Science 2003, 300:1256-1262.
5. q-GRK2-Gβγ complex. Science 2005, 310:1686-1690.
6. Lodowski D.T., Tesmer V.M., Benovic J.L., Tesmer J.J. The structure of G protein-coupled receptor kinase (GRK)-6 defines a second lineage of GRKs. J Biol Chem 2006, 281:16785-16793.
7. Boguth C.A., Singh P., Huang C.C., Tesmer J.J. Molecular basis for activation of G protein-coupled receptor kinases. EMBO J 2010, 29:3249-3259.
8. Tesmer J.J. Structure and function of regulator of G protein signaling homology domains. Prog Mol Biol Transl Sci 2009, 86:75-113.
9. Sterne-Marr R., Leahey P.A., Bresee J.E., Dickson H.M., Ho W., Ragusa M.J., Donnelly R.M., Amie S.M., Krywy J.A., Brookins-Danz E.D., et al. GRK2 activation by receptors: role of the kinase large lobe and carboxyl-terminal tail. Biochemistry 2009, 48:4285-4293.
10. Huang C.C., Yoshino-Koh K., Tesmer J.J. A surface of the kinase domain critical for the allosteric activation of G protein-coupled receptor kinases. J Biol Chem 2009, 284:17206-17215.
11. Kannan N., Haste N., Taylor S.S., Neuwald A.F. The hallmark of AGC kinase functional divergence is its C-terminal tail, a cis-acting regulatory module. Proc Natl Acad Sci U S A 2007, 104:1272-1277.
12. Metaye T., Gibelin H., Perdrisot R., Kraimps J.L. Pathophysiological roles of G protein-coupled receptor kinases. Cell Signal 2005, 17:917-928.
13. Koch W.J., Rockman H.A., Samama P., Hamilton R.A., Bond R.A., Milano C.A., Lefkowitz R.J. Cardiac function in mice overexpressing the β-adrenergic receptor kinase or a βARK inhibitor. Science 1995, 268:1350-1353.
14. Rockman H.A., Chien K.R., Choi D.J., Iaccarino G., Hunter J.J., Ross J., Lefkowitz R.J., Koch W.J. Expression of a β-adrenergic receptor kinase 1 inhibitor prevents the development of myocardial failure in gene-targeted mice. Proc Natl Acad Sci U S A 1998, 95:7000-7005.
15. Sorriento D., Santulli G., Fusco A., Anastasio A., Trimarco B., Iaccarino G. Intracardiac injection of AdGRK5-NT reduces left ventricular hypertrophy by inhibiting NF-κB-dependent hypertrophic gene expression. Hypertension 2010, 56:696-704.
16. Gold J.I., Gao E., Shang X., Premont R.T., Koch W.J. Determining the absolute requirement of G protein-coupled receptor kinase 5 for pathological cardiac hypertrophy: short communication. Circ Res 2012, 111:1048-1053.
17. Gold J.I., Martini J.S., Hullmann J., Gao E., Chuprun J.K., Lee L., Tilley D.G., Rabinowitz J.E., Bossuyt J., Bers D.M., et al. Nuclear translocation of cardiac G protein-coupled receptor kinase 5 downstream of select Gq-activating hypertrophic ligands is a calmodulin-dependent process. PLoS One 2013, 8:e57324.
18. Pitcher J.A., Inglese J., Higgins J.B., Arriza J.L., Casey P.J., Kim C., Benovic J.L., Kwatra M.M., Caron M.G., Lefkowitz R.J. Role of βγ subunits of G proteins in targeting the β-adrenergic receptor kinase to membrane-bound receptors. Science 1992, 257:1264-1267.
19. Raake P.W., Schlegel P., Ksienzyk J., Reinkober J., Barthelmes J., Schinkel S., Pleger S., Mier W., Haberkorn U., Koch W.J., et al. AAV6.βARKct cardiac gene therapy ameliorates cardiac function and normalizes the catecholaminergic axis in a clinically relevant large animal heart failure model. Eur Heart J 2013, 34:1437-1447.
20. Mayer G., Wulffen B., Huber C., Brockmann J., Flicke B., Neumann L., Hafenbradl D., Klebl B.M., Lohse M.J., Krasel C., et al. An RNA molecule that specifically inhibits G-protein-coupled receptor kinase 2 in vitro. RNA 2008, 14:524-534.
21. Tesmer V.M., Lennarz S., Mayer G., Tesmer J.J. Molecular mechanism for inhibition of G protein-coupled receptor kinase 2 by a selective RNA aptamer. Structure 2012, 20:1300-1309.
22. Benovic J.L., Stone W.C., Caron M.G., Lefkowitz R.J. Inhibition of the β-adrenergic receptor kinase by polyanions. J Biol Chem 1989, 264:6707-6710.
23. Palczewski K., McDowell J.H., Hargrave P.A. Rhodopsin kinase: substrate specificity and factors that influence activity. Biochemistry 1988, 27:2306-2313.
24. Tesmer J.J., Tesmer V.M., Lodowski D.T., Steinhagen H., Huber J. Structure of human G protein-coupled receptor kinase 2 in complex with the kinase inhibitor balanol. J Med Chem 2010, 53:1867-1870.
25. Ikeda S., Keneko M., Fujiwara S. Cardiotonic agent comprising GRK inhibitor 2007, US Patent.
26. Thal D.M., Yeow R.Y., Schoenau C., Huber J., Tesmer J.J. Molecular mechanism of selectivity among G protein-coupled receptor kinase 2 inhibitors. Mol Pharmacol 2011, 80:294-303.
27. Johnson L.N. Protein kinase inhibitors: contributions from structure to clinical compounds. Q Rev Biophys 2009, 42:1-40.
28. Thal D.M., Homan K.T., Chen J., Wu E.K., Hinkle P.M., Huang Z.M., Chuprun J.K., Song J., Gao E., Cheung J.Y., et al. Paroxetine is a direct inhibitor of G protein-coupled receptor kinase 2 and increases myocardial contractility. ACS Chem Biol 2012, 7:1830-1839.
29. Palczewski K., Buczylko J., Lebioda L., Crabb J.W., Polans A.S. Identification of the N-terminal region in rhodopsin kinase involved in its interaction with rhodopsin. J Biol Chem 1993, 268:6004-6013.
30. 2-terminal region essential for receptor phosphorylation. J Biol Chem 2003, 278:47466-47476.
31. Pao C.S., Barker B.L., Benovic J.L. Role of the amino terminus of G protein-coupled receptor kinase 2 in receptor phosphorylation. Biochemistry 2009, 48:7325-7333.
32. Huang C.C., Orban T., Jastrzebska B., Palczewski K., Tesmer J.J. Activation of G protein-coupled receptor kinase 1 involves interactions between its N-terminal region and its kinase domain. Biochemistry 2011, 50:1940-1949.
33. Orban T., Huang C.C., Homan K.T., Jastrzebska B., Tesmer J.J., Palczewski K. Substrate-induced changes in the dynamics of rhodopsin kinase (G protein-coupled receptor kinase 1). Biochemistry 2012, 51:3404-3411.
34. Homan K.T., Glukhova A., Tesmer J.J. Regulation of G protein-coupled receptor kinases by phospholipids. Curr Med Chem 2013, 20:39-46.
35. 2 adrenergic receptor-Gs protein complex. Nature 2011, 477:549-555.
36. Huang C.C., Tesmer J.J. Recognition in the face of diversity: interactions of heterotrimeric G proteins and G protein-coupled receptor (GPCR) kinases with activated GPCRs. J Biol Chem 2011, 286:7715-7721.
37. Carman C.V., Barak L.S., Chen C., Liu-Chen L.Y., Onorato J.J., Kennedy S.P., Caron M.G., Benovic J.L. Mutational analysis of Gβγ and phospholipid interaction with G protein-coupled receptor kinase 2. J Biol Chem 2000, 275:10443-10452.
38. 2 subunits change orientation upon complex formation with G protein-coupled receptor kinase 2 (GRK2) on a model membrane. Proc Natl Acad Sci U S A 2011, 108:E667-E673.
39. Thiyagarajan M.M., Stracquatanio R.P., Pronin A.N., Evanko D.S., Benovic J.L., Wedegaertner P.B. A predicted amphipathic helix mediates plasma membrane localization of GRK5. J Biol Chem 2004, 279:17989-17995.